We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PTCT market cap is 2.85B. The company's latest EPS is USD -8.1794 and P/E is -4.55.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 220.38M | 340.31M | 195.08M | 309.76M | 210.22M |
| Operating Income | -117.62M | -211.94M | -118.16M | 5.82M | -45.45M |
| Net Income | -138.96M | -198.88M | -132.97M | -155.79M | -91.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 306.98M | 380.77M | 538.59M | 698.8M | 1.07B |
| Operating Income | -241.16M | -431.77M | -374.94M | -473.31M | -439.5M |
| Net Income | -251.58M | -438.16M | -523.9M | -559.02M | -626.6M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.61B | 1.34B | 1.26B | 1.9B | 1.79B |
| Total Liabilities | 2.07B | 1.92B | 1.93B | 2.71B | 2.68B |
| Total Equity | -457.56M | -579.27M | -670.81M | -818.56M | -893.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.62B | 2.21B | 1.94B | 1.71B | 1.9B |
| Total Liabilities | 1.03B | 1.73B | 1.94B | 2.05B | 2.71B |
| Total Equity | 594.33M | 481.98M | 1.44M | -347.09M | -818.56M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.49M | -43.61M | -58.13M | -158.42M | 70.76M |
| Investing | -28.97M | -52.72M | -82.32M | -176.74M | -114.93M |
| Financing | 4.09M | 22.55M | 25.92M | 646.4M | 540k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -98.64M | -194.07M | -251.33M | -356.65M | -158.42M |
| Investing | -387.24M | -561.55M | 219.18M | 290.18M | -176.74M |
| Financing | 613.21M | 668.72M | 20.88M | 167.95M | 646.4M |
| Market Cap | 2.85B |
| Price to Earnings Ratio | -4.55 |
| Price to Sales Ratio | 2.67 |
| Price to Cash Ratio | 4.8 |
| Price to Book Ratio | -3.48 |
| Dividend Yield | - |
| Shares Outstanding | 76.61M |
| Average Volume (1 week) | 1.36M |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | -19.11% |
| 52 Week High | 48.63 |
| 52 Week Low | 17.53 |
| Spread (Intraday) | 10.29 (22.87%) |
| Company Name | PTC Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.ptcbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
